市場調査レポート

商品コード

1463409

メンタルヘルス市場の世界市場規模、シェア、成長分析、年齢層別、サービス別-産業予測、2024年～2031年

Global Mental Health Market Size, Share, Growth Analysis, By Age Group(Pediatric, Adult), By Services(Emergency Mental Health Services, Outpatient Counseling) - Industry Forecast 2024-2031

出版日: 2024年04月12日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 822,083円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 961,682円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,101,281円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.11円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のメンタルヘルス市場規模は2022年に3,996億1,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは3.5%で、2023年の4,136億米ドルから2031年には5,446億3,000万米ドルに成長する見通しです。

世界のメンタルヘルス市場は、医薬品、心理療法、デジタルヘルス・ソリューション、その他の治療介入など、予防、治療、管理を通じてメンタルヘルス障害に対処することを目的とした広範な製品とサービスを包含しています。同市場の使命は、メンタルヘルス問題に取り組む人々に効果的で利用しやすいケアを提供し、個人、家族、社会に与える負担を軽減することです。同市場の成長は、デジタルヘルス・ソリューションのような革新的な治療方法を促進する技術的進歩とともに、これらの問題に対する認識と受容の高まりと相まって、世界的にメンタルヘルス障害の有病率が高まっていることが主な要因となっています。しかし、同市場は重大な課題に直面しており、特に精神疾患を取り巻く偏見が治療を求める行動を妨げていること、特に中低所得国では訓練を受けた精神保健の専門家が不足していること、文化や社会経済的背景の違いによる治療効果のばらつきがあることなどが挙げられます。さらにこの分野は、メンタルヘルス・プログラムやサービスに対する長期的な資金や支援が不十分であることにも悩まされています。とはいえ、個別化された精密ベースの治療アプローチの可能性など、成長と革新の機会は依然として存在します。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

メンタルヘルス市場の世界市場：年齢層別

市場概要
小児科
成人用
老年病

メンタルヘルス市場の世界市場：サービス別

市場概要
緊急メンタルヘルスサービス
外来カウンセリング
在宅治療サービス
入院治療サービス
その他のサービス

メンタルヘルス市場の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Pfizer Inc.（US）
Johnson & Johnson（US）
Eli Lilly and Company（US）
Bristol-Myers Squibb（US）
GlaxoSmithKline（UK）
AstraZeneca（UK）
Allergan plc（Ireland）
Merck & Co., Inc.（US）
Takeda Pharmaceutical Company Limited（Japan）
Otsuka Holdings Co., Ltd.（Japan）
Novartis International AG（Switzerland）
Sanofi S.A.（France）
Lundbeck A/S（Denmark）
Teva Pharmaceutical Industries Ltd.（Israel）
Mylan N.V.（Netherlands）
AbbVie Inc.（US）
Boehringer Ingelheim International GmbH（Germany）
H. Lundbeck A/S（Denmark）
Sun Pharmaceutical Industries Ltd.（India）
Alkermes plc（Ireland）

Product Code: SQMIG35A2233

Global mental health market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The global Mental Health market encompasses a spectrum of products and services aimed at addressing mental health disorders through prevention, treatment, and management, including pharmaceuticals, psychotherapy, digital health solutions, and other therapeutic interventions. Its mission is to offer effective and accessible care to those grappling with mental health issues, aiming to alleviate the burdens they impose on individuals, families, and society. The market's growth is primarily fueled by the escalating prevalence of mental health disorders worldwide, coupled with increasing awareness and acceptance of these issues, alongside technological advancements fostering innovative treatment modalities like digital health solutions. However, the market faces significant challenges, notably the stigma surrounding mental illness hindering treatment-seeking behavior, a shortage of trained mental health professionals, particularly in low and middle-income nations, and the variability of treatment effectiveness across different cultural and socio-economic contexts. Additionally, the sector grapples with inadequate long-term funding and support for mental health programs and services. Nevertheless, opportunities for growth and innovation persist, including the potential for personalized and precision-based treatment approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the global mental health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mental Health Market Segmental Analysis

The global mental health market is segmented based on age group, services and region. By age group, the market is segmented into pediatric, adult, and geriatric. By services, the market is segmented into emergency mental health services, outpatient counseling, home-based treatment services, inpatient hospital treatment services, and other services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mental Health Market

The increasing prevalence of mental health disorders like depression, anxiety, and substance abuse serves as a significant catalyst for the global mental health market. This surge in mental health conditions has led to a heightened need for mental health services and treatments, consequently propelling the expansion of the market.

Restraints in the Global Mental Health Market

The restricted availability and accessibility of mental health services, especially in developing nations, pose a significant challenge for the global mental health market. This constraint limits the number of individuals able to access treatment for their mental health disorders, consequently constraining market growth.

Market Trends of the Global Mental Health Market

Telemedicine has become a prominent trend in the mental health sector. Through telemedicine, individuals can access remote mental health services like teletherapy and telepsychiatry using smartphones or computers from any location. This approach enhances accessibility and convenience for patients, especially those residing in rural or remote areas, and can also offer cost-effective solutions. Notable companies offering telemedicine services in the mental health sector include Teladoc Health and Amwell.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Mental Health Market by Age Group

Market Overview
Pediatric
Adult
and Geriatric

Global Mental Health Market by Services

Market Overview
Emergency Mental Health Services
Outpatient Counseling
Home-based Treatment Services
Inpatient Hospital Treatment Services
and Other Services

Global Mental Health Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Holdings Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H. Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alkermes plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments